Does METRELEPTIN Cause Off label use? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Off label use have been filed in association with METRELEPTIN (Myalept). This represents 4.5% of all adverse event reports for METRELEPTIN.
51
Reports of Off label use with METRELEPTIN
4.5%
of all METRELEPTIN reports
8
Deaths
23
Hospitalizations
How Dangerous Is Off label use From METRELEPTIN?
Of the 51 reports, 8 (15.7%) resulted in death, 23 (45.1%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRELEPTIN. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does METRELEPTIN Cause?
Therapy cessation (94)
Product dose omission issue (88)
Weight decreased (88)
Blood glucose increased (77)
Drug ineffective (69)
Therapy interrupted (65)
Nausea (57)
Blood triglycerides increased (49)
Treatment noncompliance (49)
Weight increased (45)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which METRELEPTIN Alternatives Have Lower Off label use Risk?
METRELEPTIN vs METRONIDAZOLE
METRELEPTIN vs METRONIDAZOLE\METRONIDAZOLE
METRELEPTIN vs METYRAPONE
METRELEPTIN vs MEXILETINE
METRELEPTIN vs MIANSERIN